Oncology & Cancer

Considerable agreement on presence of BCC on mohs slides

(HealthDay)—There is considerable interpersonal and intrapersonal agreement on the presence of basal cell carcinoma (BCC) on Mohs slides, according to a study published online April 1 in the British Journal of Dermatology.

Genetics

Team performs genomic analysis of basal cell carcinoma

The skin cancer called basal cell carcinoma (BCC) is one of the most common types of cancer. 90 per cent of the population are at risk to develop it one day, notably because of their age and exposure to the sun UV-rays. Although ...

Oncology & Cancer

Intralesional cryosurgery feasible for BCC in elderly

(HealthDay)—Intralesional cryosurgery is feasible for treating basal cell carcinoma (BCC) of the lower extremities in elderly patients, according to a study published in the March issue of the International Journal of Dermatology.

Oncology & Cancer

Age at menopause, hormone therapy linked to BCC risk

(HealthDay)—Late age at natural menopause and menopausal hormone therapy (MHT) use are associated with increased risk of basal cell carcinoma (BCC), according to a study published online Nov. 2 in the Journal of Clinical ...

Oncology & Cancer

Case of basal cell carcinoma described within port wine stain

(HealthDay)—A case of basal cell carcinoma (BCC) has been described within a port wine stain (PWS), with no preceding treatment, according to a case report published in the October issue of The Journal of Dermatology.

Medications

Odomzo approved for recurring basal cell carcinoma

(HealthDay)—Odomzo (sonidegib) has been approved by the U.S. Food and Drug Administration to treat basal cell carcinoma skin cancer that has returned despite surgery or radiation.

page 8 from 17